Publications by authors named "Lars Kristensen"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

9,608

Total Likes

1,106

Extended Reach

2,522,931

Social Features

289
E
Erratum to "Liraglutide after diet-induced weight loss for pain and weight control in knee osteoarthritis: a randomized controlled trial" Am J Clin Nutr. 2021: 113: 314-323.
Henrik Gudbergsen, Anders Overgaard, Marius Henriksen, Eva Ejlersen Wæhrens, Henning Bliddal, Lars Erik Kristensen

Am J Clin Nutr· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of Pain and Use of Analgesics in Patients With Chronic Hand Eczema-Findings From the Danish Skin Cohort.
Jeanette Halskou Haugaard, Johan Sieborg, Emma Guttman-Yassky, David Thein, Jonathan I Silverberg, Lars Erik Kristensen

Contact Dermatitis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell RNA sequencing highlights the influence of innate and adaptive immune response mechanisms in psoriatic arthritis.
Melanie R Nielsen, Marie Skougaard, Clara Drachmann, Zara R Stisen, Sisse B Ditlev, Lars Erik Kristensen

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of weight loss and liraglutide on neutrophil gelatinase-associated lipocalin levels among individuals with overweight and knee osteoarthritis: Exploratory analyses of a randomized controlled trial.
Asbjørn Seenithamby Poulsen, Zara Rebecca Stisen, Marie Skougaard, Robin Christensen, Anders Overgaard, Lars Erik Kristensen

Osteoarthr Cartil Open· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do cognitive bias and heuristics influence improvement in knee pain in patients with knee osteoarthritis treated with open label placebo? The CHIPS study - An exploratory study using questionnaire and group concept mapping.
Tommy Kok Annfeldt, Elisabeth Ginnerup-Nielsen, Eva Elisabeth Wæhrens, Lene Vase, Lars Erik Kristensen

Osteoarthr Cartil Open· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trials.
Joseph F Merola, April Armstrong, Saakshi Khattri, So Yeon Paek, Byron Padilla, Lars Erik Kristensen

J Dermatolog Treat· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of an illness perception conversation on open-label placebo response in knee osteoarthritis: A randomised controlled trial.
Elisabeth Ginnerup-Nielsen, Tanja Schjødt Jørgensen, Camilla Dew-Hattens, Robin Christensen, Johannes Iuel Berg, Lars Erik Kristensen

Osteoarthritis Cartilage· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status.
Alexis Ogdie, Lars E Kristensen, Enrique R Soriano, Servet Akar, Yanhui Sun

Rheumatol Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritis.
Dennis McGonagle, Arthur Kavanaugh, Iain B McInnes, Lars Erik Kristensen, Joseph F Merola

Rheumatology (Oxford)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52-Week Results From Two Phase 3 Studies.
Iain B McInnes, Philip J Mease, Yoshiya Tanaka, Laure Gossec, M Elaine Husni, Lars Erik Kristensen

ACR Open Rheumatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological study.
Johannes Iuel Berg, Sabrina Mai Nielsen, Esben Malm, John P A Ioannidis, Daniel E Furst, Lars Erik Kristensen

Ann Rheum Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of achieving clinical disease control criteria and patient-reported outcomes in bimekizumab-treated patients with active psoriatic arthritis: results from two phase III studies.
Lars Erik Kristensen, William Tillett, Peter Nash, Laura C Coates, Philip J Mease

Ther Adv Musculoskelet Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative early effectiveness across 14 PsA drugs and 5 classes of PsA treatment: 3-month results from the PRO-SPIRIT study.
Lars Erik Kristensen, Khai Jing Ng, Marcus Ngantcha, Jacques Morel, Ennio Lubrano

RMD Open· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and drivers of fatigue in patients with psoriasis and psoriatic arthritis: A cross sectional study.
Lea Nymand, Lars Erik Kristensen, Simon Francis Thomsen, Jacob P Thyssen, Alexander Egeberg

J Am Acad Dermatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial.
Lars Erik Kristensen, Mauro Keiserman, Kim Papp, Leslie McCasland, Douglas White

Rheumatol Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data.
Lars Erik Kristensen, Atul Deodhar, Ying-Ying Leung, Ivana Vranic, Mahta Mortezavi

Rheumatol Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight Loss for Patients With Gout and Concomitant Obesity: A Proof-of-Concept Randomized Trial.
Robin Christensen, Kristian Zobbe, Sabrina M Nielsen, Lisa K Stamp, Marius Henriksen, Lars Erik Kristensen

Arthritis Rheumatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update.
Laure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, Daniel Aletaha, Xenofon Baraliakos, Lars Erik Kristensen

Ann Rheum Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study.
Virginia Solitano, Paola Facheris, Magnus Petersen, Ferdinando D'Amico, Michela Ortoncelli, Lars Erik Kristensen

Autoimmun Rev· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician.
Zoltán Szekanecz, Maya H Buch, Christina Charles-Schoeman, James Galloway, George A Karpouzas, Lars Erik Kristensen

Nat Rev Rheumatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Inflammatory Cytokines in Responders and Non-Responders to TNFα Inhibitor and IL-17A Inhibitor: A Study Examining Psoriatic Arthritis Patients.
Marie Skougaard, Magnus Friis Søndergaard, Sisse Bolm Ditlev, Lars Erik Kristensen

Int J Mol Sci· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician.
Zoltán Szekanecz, Maya H Buch, Christina Charles-Schoeman, James Galloway, George A Karpouzas, Lars Erik Kristensen

Nat Rev Rheumatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health inequities and societal costs for patients with fibromyalgia and their spouses: a Danish cohort study.
Kirstine Amris, Rikke Ibsen, Pernille Hurup Duhn, Judi Olsen, Karoline Lolk, Lars Erik Kristensen

RMD Open· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring disease-related and treatment-related issues and concerns experienced by adults with spondyloarthritis, inflammatory bowel disease and psoriasis to identify unmet needs: a qualitative clinical concept mapping study.
Zara R Stisen, Marie Skougaard, Katrine Risager Christensen, Mark Andrew Ainsworth, Rebekka Lund Hansen, Lars Erik Kristensen

BMJ Open· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis